首页> 外文学位 >The chronologic effects of atorvastatin: Morning versus evening administration in hyperlipidemic adults.
【24h】

The chronologic effects of atorvastatin: Morning versus evening administration in hyperlipidemic adults.

机译:阿托伐他汀的时间效应:高脂血症成年人的早晚服用。

获取原文
获取原文并翻译 | 示例

摘要

Objective. To compare the lipid lowering effects [total cholesterol (Total-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C)], of a morning dose (before 12 PM) and an evening dose (after 6 PM and before 12 AM) of atorvastatin 40 mg, in veteran patients diagnosed with hyperlipidemia.;Methods. Sixty-four male patients, over the age of 50, from the New York Veterans Administration Harbor Health Care System (NYVAHHCS) ambulatory care clinic, were retrospectively (58 patients), and prospectively (6 patients), enrolled and evaluated. In the retrospective study, data on drug dosing, time of administration, and lipoprotein profiles were obtained from computerized records. Twenty-nine patients who received atorvastatin in the morning were compared to 29 patients who received atorvastatin in the evening. As for the patients prospectively enrolled, each patient was randomized to receive atorvastatin in the morning or in the evening. The baseline serum lipid parameters were compared to the follow-up values. Patients were excluded from the study if they were receiving any antihyperlipidemic medications other than atorvastatin, started on medications known to affect lipids (within last 4 months), and/or newly diagnosed with a disease known to affect serum lipoproteins. The various serum lipoprotein profiles for each patient were obtained for analysis. The two-tailed Student's t-test was utilized to compare the mean percent reduction in the lipid parameters between morning and evening atorvastatin administration. Statistical significance was set at 95 with a p < 0.05.;Results. Retrospective Study. The percent reduction following morning and evening atorvastatin administration were as follows: Total-C levels 34.7% vs 34.6% (p = .504), LDL-C levels 47.6% vs 46.6% (p = .942), TG levels 29.5% vs 28.1% (p = 0.228), respectively. The percent increase in HDL-C following morning and evening administration was 7.3 vs 7.6% (p = 0.331), respectively.;Prospective Study. The percent reduction following morning and evening atorvastatin administration were as follows: Total-C levels 34.5% vs 35%, LDL-C levels 47.2% vs 46.9%, TG levels 24.1% vs 25.7%, respectively. The percent increase in HDL-C following morning and evening administration was 4.8% vs 2.6%, respectively.;Conclusion. No statistically significant differences were found between the group that received atorvastatin in the morning versus the group that received atorvastatin in the evening. Morning and evening atorvastatin administration equally reduced the serum Total-C, LDL-C, and TG levels and equally increased serum HDL-C levels. The findings of this study indicate that atorvastatin exerts a similar effect on the lipoprotein parameters regardless of administration time.
机译:目的。比较早剂量(之前的总胆固醇)的降脂效果[总胆固醇(Total-C),低密度脂蛋白胆固醇(LDL-C),甘油三酸酯(TG)和高密度脂蛋白胆固醇(HDL-C)]在诊断为高脂血症的退伍军人患者中,阿托伐他汀40 mg每天晚上12点服用,晚上服用阿托伐他汀40 mg(晚上6点之后和12点之前)。回顾性分析了纽约退伍军人管理局港口卫生保健系统(NYVAHHCS)门诊医疗诊所的64名年龄在50岁以上的男性患者(58例)和前瞻性(6例)。在回顾性研究中,有关药物剂量,给药时间和脂蛋白谱的数据是从计算机记录中获得的。将29例早晨接受阿托伐他汀的患者与29例夜间接受阿托伐他汀的患者进行比较。对于预期入组的患者,每位患者在早晨或晚上随机接受阿托伐他汀治疗。将基线血脂参数与随访值进行比较。如果患者正在接受除阿托伐他汀以外的任何抗高血脂药物,开始使用已知会影响脂质的药物(最近4个月内)和/或新诊断出患有已知会影响血清脂蛋白的疾病,则将其排除在研究范围之外。获得每位患者的各种血清脂蛋白谱以进行分析。使用两尾学生t检验比较早晨和晚上服用阿托伐他汀之间脂质参数的平均降低百分比。统计显着性设为95,p <0.05。回顾性研究。早晨和晚上服用阿托伐他汀后的减少百分比如下:总C水平34.7%vs 34.6%(p = .504),LDL-C水平47.6%vs 46.6%(p = .942),TG水平29.5%vs分别为28.1%(p = 0.228)。早晨和晚上给药后,HDL-C的增加百分比分别为7.3对7.6%(p = 0.331)。早晨和晚上服用阿托伐他汀后的减少百分比如下:总C水平分别为34.5%对35%,LDL-C水平47.2%对46.9%,TG水平24.1%对25.7%。早晨和晚上给药后,HDL-C的增加百分比分别为4.8%和2.6%。早上接受阿托伐他汀的组与晚上接受阿托伐他汀的组之间没有统计学上的显着差异。早晨和晚上服用阿托伐他汀均能降低血清Total-C,LDL-C和TG水平,并同样提高血清HDL-C水平。这项研究的结果表明,无论给药时间如何,阿托伐他汀对脂蛋白参数的作用相似。

著录项

  • 作者

    Plakogiannis, Roda.;

  • 作者单位

    Long Island University, The Brooklyn Center.;

  • 授予单位 Long Island University, The Brooklyn Center.;
  • 学科 Pharmaceutical sciences.
  • 学位 Pharm.D.
  • 年度 2001
  • 页码 89 p.
  • 总页数 89
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号